Prostate cancer research funding in the US budget for FY16


The “New” Prostate Cancer InfoLink is pleased to note that, in the final draft of the Omnibus reconciliation bill designed to fund the US federal government from October 1, 2015 through September 31, 2016 (the FY16 budget) there are two important pieces of news for the prostate cancer community.

First and foremost, the Department of Defense’s Congressionally Directed Medical Research Program (CDMRP) again contains $80 million to fund the CDRMP’s Prostate Cancer Research Project. While many would like to see this raised to more like $120 million each year, the important thing, given the current political situation here in the US, is that there was no cut to the current funding level.

Second, and nearly as important, the bill has restored funding of $13.2 million for prostate cancer-related activities executed at the Centers for Disease Control (CDC). Funding for such programs had been cut in the recent past, and there was real concern that such funding might not be restored.

While the Omnibus bill still needs to be voted on and approved by the House of Representatives and the Senate, it seems highly likely that both houses will approve this bill in short order and that it will be promptly signed into law by the President. Some Republican members of Congress may be less than entirely happy about this Omnibus bill, but The “New” Prostate Cancer InfoLink is please to see that most members of Congress still seem to be able to find common ground about issues that are truly important to the day-to-day management of the country. (The same can not be said of the State of Pennsylvania, where your sitemaster resides, and which has now failed to approve a budget for FY16 that should have been passed months ago!)

One Response

  1. A Welcome Change in the Air?

    Thanks very much for this welcome news!

    I have been deeply disturbed that, for more than a decade, the Republican Party has been blowing the bugle for retreat in the War on Cancer, primarily by preventing funding increases pegged to medical research inflation, through outright budget cuts in the NIH/NCI budgets, and through cuts via the sequester.

    I once did a survey of candidate websites, and it was stunning how oblivious Republican Party candidates were to the need for medical and particularly cancer research in contrast to strong support from the vast majority of Democratic Party candidates. There were welcome exceptions on the Republican side, and a few Democrats who did not care; in fact, former Republican Rep. Cliff Stearns of Florida, a right-wing “birther”, actually played a key role in funding prostate cancer research managed by the DoD (the PCRP — Prostate Cancer Research Program) of the CDMRP – Congressionally Directed Medical Research Program).

    Recent news articles have reported that the newly elected Speaker of the House Paul Ryan is playing a leadership role in managing compromises that lead to a budget, and my impression is this includes loosening up funding for cancer research. I’m hoping he keeps that up!

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: